demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 severe or critically
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies
colchicine COLCHIVID Brunetti
stem cells Shu Shi
vilobelimab (IFX-1) PANAMO
corticosteroids Lu Raef Jianfeng Tomasz Salton ... Monreal
dexamethasone DEXA-COVID19 CODEX ... Jamaati Rashad Naik
Dexamethasone 12mg COVID STEROID 2
Hydrocortisone CAPE-COVID REMAP-CAP, fixed 7-day course REMAP-CAP, shock-dependent course Munch ...
methylprednisolone Steroids-SARI Edalatifard Farahani Belhassen-Garc??a
Immunostimulants drugs
convalescent plasma treatment CP-COVID-19 ILBS-COVID-02 ... Duan Li Sean Rasheed Hegerova O’Donnell PlasmAr CAPSID AlQahtani Joyner REMAP-CAP ... RECOVER PICP19 ... Bihariesingh-Sanchit ... Pouladzadeh Sekine ... Ray
immunoglobulin therapy Tabarsi Gharebaghi Raman
interferon
IFN beta-1a Davoudi-Monfared Darazam ... Kalil ...
IFN beta-1b Rahmani Darazam ...
neutralizing antibody
equine polyclonal antibodies INM005 Lopardo
Immunosuppressants drugs
abatacept ACTIV-1 abatacept
adalimumab Fakharian
anakinra Ana-COVID ... Kooistra
anti-interleukin-6
Levilimab V.Lomakin ...
sarilumab sarilumab Sanofi phase 3 US ARI-RAF ... sarilumab Sanofi phase 3 outside US REMAP-CAP sarilumab
sarilumab high dose (400mg) Lescure ...
sarilumab low dose (200mg) Lescure ...
tocilizumab TOCI-RAF Study Group ... Rojas-Marte Somers Mathilde Andrew MARIPOSA Biran COVACTA ... Pereira CORIMUNO-TOCI-1 ... REMAP-CAP ... Veiga Rashad Talaschian Hamed Karampitsakos CORIMUNO-TOCI-ICU ... NCT04377750 ... Rosas ... Karakike ... Belhassen-Garc??a Sarhan Sarhan
canakinumab CAN-COVID
cenicriviroc ACTIV-1 cenicriviroc
infliximab ACTIV-1 infliximab
itolizumab Kumar
janus kinase (JAK) inhibitor
baricitinib Tziolos COV-BARRIER ...
ruxolitinib Cao DEVENT
TD-0903
TD-0903 10mg Singh ...
TD-0903 1mg Singh ...
TD-0903 3mg Singh ...
tacrolimus TACROVID
thalidomide Amra
Kinase inhibitors
imatinib Aman
statins
Atorvastatin INSPIRATION-S

0 studies excluded by filtering options 2